73 Intravenous immunization with an attenuated whole malaria sporozoite vaccine protected volunteers in a phase I clinical trial.
http://www.sciencemag.org/content/341/6152/1359.abstract
72 Mice Infected with Low-Virulence Strains of Toxoplasma gondii Lose Their Innate Aversion to Cat Urine, Even after Extensive Parasite Clearance.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0075246
71 A Transcriptomic Network Identified in Uninfected Macrophages Responding to Inflammation Controls Intracellular Pathogen Survival.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00286-2
70 Vaccination with Leishmania Hemoglobin Receptor–Encoding DNA Protects Against Visceral Leishmaniasis.
http://stm.sciencemag.org/content/5/202/202ra121.abstract
69 Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent.
http://www.nature.com/srep/2013/130826/srep02501/full/srep02501.html
68 A Microscale Human Liver Platform that Supports the Hepatic Stages of Plasmodium falciparum and vivax.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00221-7
67 Leishmania Evades Host Immunity by Inhibiting Antigen Cross-Presentation through Direct Cleavage of the SNARE VAMP8.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00219-9
66 Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria.
http://jem.rupress.org/content/210/8/1635.abstract
65 Disrupting malaria parasite AMA1–RON2 interaction with a small molecule prevents erythrocyte invasion.
http://www.nature.com/ncomms/2013/130802/ncomms3261/full/ncomms3261.html
64 Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins.
http://www.pnas.org/content/110/30/E2838.abstract
|
